Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

IN VITRO METABOLISM OF THE CALMODULIN ANTAGONIST DY-9760e (3-[2-[4-(3-CHLORO-2-METHYLPHENYL)-1-PIPERAZINYL]ETHYL]-5,6-DIMETHOXY-1-(4-IMIDAZOLYLMETHYL)-1H-INDAZOLE DIHYDROCHLORIDE 3.5 HYDRATE) BY HUMAN LIVER MICROSOMES: INVOLVEMENT OF CYTOCHROMES P450 IN ATYPICAL KINETICS AND POTENTIAL DRUG INTERACTIONS

Shuko Tachibana, Yuko Fujimaki, Hiroyuki Yokoyama, Osamu Okazaki and Ken-ichi Sudo
Drug Metabolism and Disposition November 2005, 33 (11) 1628-1636; DOI: https://doi.org/10.1124/dmd.105.004903
Shuko Tachibana
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuko Fujimaki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroyuki Yokoyama
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Osamu Okazaki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ken-ichi Sudo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 33 no. 11 1628-1636
DOI 
https://doi.org/10.1124/dmd.105.004903
PubMed 
16049129

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received April 1, 2005
  • Accepted July 22, 2005
  • Published online October 26, 2005.

Article Versions

  • Earlier version (July 27, 2005 - 10:28).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Shuko Tachibana,
  2. Yuko Fujimaki,
  3. Hiroyuki Yokoyama,
  4. Osamu Okazaki and
  5. Ken-ichi Sudo
  1. Drug Metabolism and Physicochemistry Research Laboratories, R&D Division, Daiichi Pharmaceutical Co., Ltd., Tokyo, Japan (S.T., Y.F., O.O., K.S.); and Mitsubishi Chemical Safety Institute Ltd., Kashima Laboratory, Ibaraki, Japan (H.Y.)
  1. Address correspondence to:
    Shuko Tachibana, Drug Metabolism & Physicochemistry Research Laboratories, R&D Division, Daiichi Pharmaceutical Co., Ltd., 1-16-13, Kita-kasai, Edogawa-ku, Tokyo 134-8630, Japan. E-mail: tachiroq{at}daiichipharm.co.jp
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: July 2005 to June 2022

AbstractFullPdf
Jul 20055029
Aug 200527090
Sep 20057055
Oct 2005381364
Nov 2005605957
Dec 2005232221
Jan 200632922
Feb 2006242019
Mar 2006221010
Apr 200610117
May 2006879
Jun 20061626
Jul 2006879
Aug 20067107
Sep 20061459
Oct 20061755
Nov 200681414
Dec 20067102
Jan 20077411
Feb 200761210
Mar 200761319
Apr 2007191612
May 200761711
Jun 2007798
Jul 20078125
Aug 20078713
Sep 20072115
Oct 2007141916
Nov 20078613
Dec 200751415
Jan 2008867
Feb 2008462
Mar 2008569
Apr 20088916
May 200810139
Jun 200831514
Jul 2008171723
Aug 200827229
Sep 20081662610
Oct 200824913
Nov 200852810
Dec 2008278
Jan 2009346
Feb 20093813
Mar 200982114
Apr 2009589
May 2009236
Jun 2009577
Jul 20098108
Aug 20098107
Sep 2009101716
Oct 20091668
Nov 20091545
Dec 20091768
Jan 20101726
Feb 20102357
Mar 20101646
Apr 20101635
May 20104536
Jun 20102145
Jul 20101317
Aug 20101575
Sep 20101451
Oct 201051311
Nov 2010945
Dec 20101883
Jan 2011765
Feb 2011758
Mar 20112910
Apr 20119910
May 201118714
Jun 20111434
Jul 201116128
Aug 2011221310
Sep 201111156
Oct 201119157
Nov 201121913
Dec 201115910
Jan 201212119
Feb 20122288
Mar 20122658
Apr 201218814
May 2012111416
Jun 20121696
Jul 201216410
Aug 2012181210
Sep 201214716
Oct 20121639
Nov 2012281219
Dec 20121453
Jan 201329139
Feb 20132775
Mar 2013231010
Apr 20131569
May 20131379
Jun 2013937
Jul 20131103
Aug 2013405
Sep 20132144
Oct 20132947
Nov 20131308
Dec 2013556
Jan 20141124
Feb 20141034
Mar 2014858
Apr 20141247
May 201419108
Jun 2014784
Jul 20141546
Aug 2014585
Sep 2014873
Oct 201410210
Nov 2014763
Dec 201413424
Jan 20158173
Feb 2015281
Mar 20151144
Apr 2015833
May 20151072
Jun 20158132
Jul 2015131011
Aug 20151055
Sep 2015833
Oct 2015320
Nov 20159289
Dec 2015434
Jan 20161088
Feb 2016113
Mar 20163611
Apr 2016031
May 20167127
Jun 20163438
Jul 20164320
Aug 20163915
Sep 2016403
Oct 20161141
Nov 2016356
Dec 2016117
Jan 20172164
Feb 2017075
Mar 20170117
Apr 2017021
May 2017075
Jun 20171176
Jul 20172165
Aug 201712410
Sep 20170185
Oct 20170189
Nov 201701714
Dec 201722310
Jan 20180121
Feb 20181172
Mar 20181345
Apr 20180142
May 20180143
Jun 20183195
Jul 20181104
Aug 20180102
Sep 20180120
Oct 2018071
Nov 20180133
Dec 2018942
Jan 20191727
Feb 2019801
Mar 20191011
Apr 20193034
May 20191922
Jun 20199312
Jul 2019915
Aug 20191502
Sep 20191801
Oct 20191504
Nov 20191010
Dec 20194003
Jan 20201515
Feb 2020712
Mar 20201101
Apr 2020921
May 2020402
Jun 2020911
Jul 2020400
Aug 2020501
Sep 2020210
Oct 2020811
Nov 2020601
Dec 20201312
Jan 2021613
Feb 2021714
Mar 20212014
Apr 2021910
May 20211332
Jun 20211224
Jul 20211222
Aug 2021611
Sep 20211330
Oct 2021911
Nov 20211410
Dec 20211610
Jan 2022733
Feb 20221323
Mar 20221031
Apr 20221432
May 20221131
Jun 2022510

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 33 (11)
Drug Metabolism and Disposition
Vol. 33, Issue 11
1 Nov 2005
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
IN VITRO METABOLISM OF THE CALMODULIN ANTAGONIST DY-9760e (3-[2-[4-(3-CHLORO-2-METHYLPHENYL)-1-PIPERAZINYL]ETHYL]-5,6-DIMETHOXY-1-(4-IMIDAZOLYLMETHYL)-1H-INDAZOLE DIHYDROCHLORIDE 3.5 HYDRATE) BY HUMAN LIVER MICROSOMES: INVOLVEMENT OF CYTOCHROMES P450 IN …
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

IN VITRO METABOLISM OF THE CALMODULIN ANTAGONIST DY-9760e (3-[2-[4-(3-CHLORO-2-METHYLPHENYL)-1-PIPERAZINYL]ETHYL]-5,6-DIMETHOXY-1-(4-IMIDAZOLYLMETHYL)-1H-INDAZOLE DIHYDROCHLORIDE 3.5 HYDRATE) BY HUMAN LIVER MICROSOMES: INVOLVEMENT OF CYTOCHROMES P450 IN ATYPICAL KINETICS AND POTENTIAL DRUG INTERACTIONS

Shuko Tachibana, Yuko Fujimaki, Hiroyuki Yokoyama, Osamu Okazaki and Ken-ichi Sudo
Drug Metabolism and Disposition November 1, 2005, 33 (11) 1628-1636; DOI: https://doi.org/10.1124/dmd.105.004903

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

IN VITRO METABOLISM OF THE CALMODULIN ANTAGONIST DY-9760e (3-[2-[4-(3-CHLORO-2-METHYLPHENYL)-1-PIPERAZINYL]ETHYL]-5,6-DIMETHOXY-1-(4-IMIDAZOLYLMETHYL)-1H-INDAZOLE DIHYDROCHLORIDE 3.5 HYDRATE) BY HUMAN LIVER MICROSOMES: INVOLVEMENT OF CYTOCHROMES P450 IN ATYPICAL KINETICS AND POTENTIAL DRUG INTERACTIONS

Shuko Tachibana, Yuko Fujimaki, Hiroyuki Yokoyama, Osamu Okazaki and Ken-ichi Sudo
Drug Metabolism and Disposition November 1, 2005, 33 (11) 1628-1636; DOI: https://doi.org/10.1124/dmd.105.004903
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Improved CYP Reaction Phenotyping
  • Multiple-Concentration Chemical Inhibition Design
  • New Dog P450 3A98 in Gut
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics